Document Detail

Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging.
MedLine Citation:
PMID:  17061044     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Arthralgia, skeletal and muscle pain have been reported in postmenopausal women under treatment with third generation aromatase inhibitors (AIs). However, the pathogenesis and anatomic correlate of musculoskeletal pains have not been thoroughly evaluated. Moreover, the impact of AI-induced musculoskeletal symptoms on normal daily functioning needs to be further explored. PATIENTS AND METHODS: We examined 12 consecutive non-metastatic breast cancer patients who reported severe musculoskeletal pain under a third generation AI; 11 were on letrozole and 1 on exemestane. Clinical rheumatological examination and serum biochemistry were performed. Radiological evaluation of the hand/wrist joints were performed using ultrasound (US) and/or magnetic resonance imaging (MRI). RESULTS: The most common reported symptom was severe early morning stiffness and hand/wrist pain causing impaired ability to completely close/stretch the hand/fingers and to perform daily activities and work-related skills. Six patients had to discontinue treatment due to severe symptoms. Trigger finger and carpal tunnel syndrome were the most frequently reported clinical signs. US showed fluid in the tendon sheath surrounding the digital flexor tendons. On MRI, an enhancement and thickening of the tendon sheath was a constant finding in all 12 patients. CONCLUSIONS: Musculoskeletal pains in breast cancer patients under third generation AIs can be severe, debilitating, and can limit compliance. Characteristic tenosynovial, and in some patients joint changes on US and MRI were observed in this series and have not been reported before.
Leilani Morales; Steven Pans; Robert Paridaens; Rene Westhovens; Dirk Timmerman; Johan Verhaeghe; Hans Wildiers; Karin Leunen; Frederic Amant; Patrick Berteloot; Ann Smeets; Erik Van Limbergen; Caroline Weltens; Walter Van den Bogaert; Luc De Smet; Ignace Vergote; Marie-Rose Christiaens; Patrick Neven
Related Documents :
20346594 - Comparison of transverse carpal ligament and flexor retinaculum terminology for the wrist.
22782914 - The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibi...
10529064 - Ct examination of the manipulation system in the giant panda (ailuropoda melanoleuca).
22696044 - Multidetector ct cystography for imaging colovesical fistulas and iatrogenic bladder le...
21939774 - In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neurobl...
10512234 - Cavernous sinus and inferior petrosal sinus flow signal on three-dimensional time-of-fl...
Publication Detail:
Type:  Journal Article     Date:  2006-10-24
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  104     ISSN:  0167-6806     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-06-25     Completed Date:  2007-09-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  87-91     Citation Subset:  IM    
Department of General Medical Oncology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Androstadienes / adverse effects*
Aromatase Inhibitors / adverse effects*
Breast Neoplasms / drug therapy*,  pathology
Carpal Tunnel Syndrome / chemically induced,  pathology,  ultrasonography
Magnetic Resonance Imaging
Middle Aged
Musculoskeletal Diseases / chemically induced*,  pathology,  ultrasonography
Nitriles / adverse effects*
Pain / chemically induced,  pathology
Severity of Illness Index
Triazoles / adverse effects*
Wrist Joint / pathology,  ultrasonography
Reg. No./Substance:
0/Androstadienes; 0/Aromatase Inhibitors; 0/Nitriles; 0/Triazoles; 107868-30-4/exemestane; 112809-51-5/letrozole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer.
Next Document:  CDKN2A-positive breast cancers in young women from Poland.